Walgreens Statement in Support of President-Elect Biden’s COVID-19 Update
- 62
Following President-elect Joe Biden’s COVID-19 Update, Walgreens issued the following statement from John Standley, Walgreens president.
“Walgreens applauds President-elect Biden plan to accelerate vaccine distribution efforts by utilizing pharmacies across the country. With our nationwide footprint, extensive vaccine experience, trusted community presence and pharmacy expertise, Walgreens is well-positioned to administer COVID-19 vaccines and help our nation emerge from this pandemic.
While we have been vaccinating our most vulnerable population in long-term care facilities since late December, our team members embedded in the communities we serve stand ready, willing and able to vaccinate in our stores. We look forward to working with the president-elect to expand vaccines in a way that is convenient and equitable for all Americans.”
About Walgreens
Walgreens (www.walgreens.com) is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), a global leader in retail and wholesale pharmacy. As America’s most loved pharmacy, health and beauty company, Walgreens purpose is to champion the health and wellbeing of every community in America. Operating more than 9,000 retail locations across America, Puerto Rico and the U.S. Virgin Islands, Walgreens is proud to be a neighborhood health destination serving approximately 8 million customers each day. Walgreens pharmacists play a critical role in the U.S. healthcare system by providing a wide range of pharmacy and healthcare services. To best meet the needs of customers and patients, Walgreens offers a true omnichannel experience, with platforms bringing together physical and digital, supported by the latest technology to deliver high-quality products and services in local communities nationwide.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210115005596/en/
- Business First Bancshares, Inc., Announces Financial Results for Q1 2024
- BENCHMARK ELECTRONICS TO REPORT FIRST QUARTER 2024 RESULTS
- Seacoast Reports First Quarter 2024 Results
- Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
- Outbrain to Release First Quarter 2024 Financial Results on May 9, 2024
- Y-mAbs to Present at 2024 ASCO Annual Meeting